Disc Medicine Inc. (IRON)

Disc Medicine Inc. (IRON) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3B; returns 1 day -0.7%, 1 week +31.1%, 1 year -11.0%.

Disc Medicine, Inc. (NASDAQ:IRON) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company aims to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis.

Groups IRON belongs to

• Biotechnology
• Clinical Stage Biotech
• Hematology
• Healthcare
• Clinical Stage
• Life Sciences
• Rare Diseases
• Biopharmaceutical
• Drug Discovery

IRON financial model: income statement, cash flow and balance sheet